BIB — ProShares Ultra Nasdaq Biotechnology

—
NGM · Derivatives · Trading · CIK ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
No quarterly fundamentals indexed for this ticker.

Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $90.00 · spot: $108.38 · call volume: 178 · put volume: 27
Expected Move to 2027-02-19: ±$20.65 (19.05%) — implied range $87.73 – $129.03 · ATM straddle on $110.00 strike

Recent Insider Activity

No insider activity indexed for this ticker.